DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.
Firms / A••••• C•••••• P•••••••• L•••
A••••• C•••••• P•••••••• L•••
Private equity with venture activity · probableGreenwich, CTa•••••••••.comSEC registered investment adviser
Middle-market private equity firm focused exclusively on healthcare, partnering with management teams to build industry leaders.
registered adviser; venture funds are 0% of 7 private funds
Importance
35
elevated
Active deployment
40
elevated
Emerging
0
low
Completeness
69
high
Freshness
99
high
Research priority
16
moderate
Identity and regulatory footprint
- Headquarters
- Greenwich, CTadviserinfo.sec.gov
- Office address
- 1 LAFAYETTE PLACE, SUITE 301, Greenwich, CT, 06830adviserinfo.sec.gov
- Business phone
- 646-561-6655adviserinfo.sec.gov
- Website
- a•••••••••.com
- SEC adviser type
- registered investment adviseradviserinfo.sec.gov
- SEC exemption claimed
- unknown
- Latest Form ADV
- Jun 11, 2024
- Private funds reported
- 7 (0 venture capital funds)adviserinfo.sec.gov
- Private fund gross assets
- $1.4Badviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
- Regulatory AUM
- $2.7Bthe adviser's RAUM, a regulatory measure, never a fund size
- Employees
- 15
- Owners on Schedule A
- A••••• C•••••• P•••••••• L••••• (General Partner), NA
- business email
- info@amuletcapital.comamuletcapital.compublished by the subject
- business phone
- 646-561-6655adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
4 observed deals
Stated (the firm’s website)
- Sectors
- healthcare, biotech
- Stages
- not stated or not yet read
- Geography
- global
- Check size
- not stated; DFX does not estimate checks from round sizes
Observed (from deals on record)
Stage at participation: no observed deals yet
Stage at first entry: no observed deals yet
Sectors
unknown 100%
lead rate n/afollow-on rate n/anew logos, 12 months 4
Funds and vehicles
3 reported
| Vehicle | Type | Vintage | Lifecycle | Reported GAV | Owners | Form D sold | Latest Form D |
|---|---|---|---|---|---|---|---|
| A• H• S••• L•• | SPV or co-invest vehicle | 2024 form d first sale | Early deployment | unknown | unknown | $1.1M of $1.1M | Sep 17, 2024 |
| A• B• S••• L•• | SPV or co-invest vehicle | 2024 form d first sale | Newly closed | unknown | unknown | $1.3M of $1.3M | Apr 3, 2025 |
| A••••• C•••••• F••• I• L••• | Fund · ADV: Private Equity Fund | 2015 form d first sale | Harvest | $239M Jun 11, 2024 | 10 | $145M of $250M | Jul 1, 2016 |
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
32 current, 4 departed
C•••• C•••••••
AssociateAssociate
M•• K••••••
AssociateAssociate
R••••• M••••••••
AssociateAssociate
T•••• M•••••
AssociateAssociate
V••••• M•••••••
AssociateAssociate
L•••• E•••••••••
Investor relationsVice President, Investor Relations
M•••••• K•••••••
Investor relationsPartner, Head of Investor Relations
A••• G•••••••
Managing partnerManaging Partner
J•• B• R•••
Managing partnerManaging Member · since Jul 1, 2012
J•• R•••
Managing partnerPresident, Managing Partner
R••••• A••• F••••
Managing partnerManaging Member · since Jun 1, 2012
R••••• F••••
Managing partnerCEO, Managing Partner
F••• O••••••••
OtherInvestment Professionals
H••••••••• F••••
OtherInvestment Criteria
T•• T•••••
OtherHead of Portfolio Resource Group
V•••• C•••••••
OtherPortfolio
A•• U•••••••••
PartnerPartner
C••• Z••••••••
PartnerPartner
S•• B•••••••
PartnerPartner
D••• B••••••
Platform and operationsOffice Operations Administrator
F•••• S•••••
Platform and operationsChief Financial Officer & Chief Compliance Officer
F•••• S•••••
Platform and operationsChief Financial Officer / Chief Compliance Officer · since May 1, 2022
J•••• G••••••••
Platform and operationsExecutive Assistant
K•••• M••••••
Platform and operationsExecutive Assistant
C•••••• K••••••
PrincipalPrincipal, V•••• C•••••••
T••• S•••
PrincipalPrincipal
A••••• P••••••••
Vice presidentVice President
C•••• N••••••••
Vice presidentVice President
J•••• K•••
Vice presidentVice President
K••• J•••••
Vice presidentSenior Vice President
S•••• B•••••
Vice presidentVice President, V•••• C•••••••
W•••••• A• K•••
Vice presidentVice President
4 departed (kept with end dates)
- A•• J•••• B••••••••• · Senior Managing Director · Jul 1, 2012 to Aug 25, 2015 Inference
- G••••• L• F••••••• · Senior Managing Director · Jul 1, 2012 to Aug 25, 2015 Inference
- T••••• L• C•••• · Chief Compliance Officer · Jan 1, 2021 to May 11, 2022 Inference
- W•••••• J• D••••• · Cfo/Cco · Jul 1, 2013 to Aug 25, 2015 Inference
Investments on record
4 edges, 4 companies, 0 partner-attributed
| Company | Round | Role | Partner | Round size | This investor | Date | Source |
|---|---|---|---|---|---|---|---|
| A•••••••• I••••••••• | portfolio listing | unknown | unknown | unknown | unknown | Sep 16, 2026 | Fact Venture organization websites (about, team, portfolio, thesis, news pages) |
| O••• H••••• | portfolio listing | unknown | unknown | unknown | unknown | Sep 16, 2026 | Fact Venture organization websites (about, team, portfolio, thesis, news pages) |
| U••• D•••••••• H••••• | portfolio listing | unknown | unknown | unknown | unknown | Sep 16, 2026 | Fact Venture organization websites (about, team, portfolio, thesis, news pages) |
| U••••• V••• ••• • V••••••• C•••••• | portfolio listing | unknown | unknown | unknown | unknown | Sep 16, 2026 | Fact Venture organization websites (about, team, portfolio, thesis, news pages) |
“This investor” is the amount disclosed for this investor alone; it is unknown unless a source said it. The round size is the whole round.
Co-investors
0 relationships from shared deals, counted for the whole firm
No co-investor relationship yet: these are derived only from rounds and portfolio listings the graph has seen both investors on.
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
9 dated events
- May 11, 2022T••••• L• C•••• (Chief Compliance Officer) no longer on Schedule A of A••••• C•••••• P•••••••• L•••
- Jan 1, 2021T••••• L• C•••• joined Schedule A of A••••• C•••••• P•••••••• L••• as Chief Compliance Officer
- Jun 1, 2019F•••• S••••• joined Schedule A of A••••• C•••••• P•••••••• L••• as Chief Financial Officer
- Aug 25, 2015G••••• L• F••••••• (Senior Managing Director) no longer on Schedule A of A••••• C•••••• P•••••••• L•••
- Aug 25, 2015A•• J•••• B••••••••• (Senior Managing Director) no longer on Schedule A of A••••• C•••••• P•••••••• L•••
- Aug 25, 2015W•••••• J• D••••• (Cfo/Cco) no longer on Schedule A of A••••• C•••••• P•••••••• L•••
- Jul 15, 2014A••••• C•••••• P•••••••• L••• first filed Form ADV (IA)First SEC adviser filingOrganizationFactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Jul 15, 2014A••••• C•••••• F••• I• L••• first reported on Form ADV by A••••• C•••••• P•••••••• L••• (Private Equity Fund)Fund first reported on Form ADVFundsFactA••••• C•••••• F••• I• L•••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Jul 1, 2012G••••• L• F••••••• joined Schedule A of A••••• C•••••• P•••••••• L••• as Senior Managing Director
Classification history
- Sep 12, 2026Private equity with venture activity (probable, 75%, cls-1)registered adviser; venture funds are 0% of 7 private funds
Evidence
46 observations from 2 sources